Metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor (TGFβ) in pleural tuberculosis

L. Antonangelo, R. Sales, L. Teixeira, E. Genofre, R. Onishi, M. Valim, M. Seiscento, F. Vargas (Sao Paulo, Brazil)

Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Session: Genetics, immunology and microbiology of tuberculosis
Session type: E-Communication Session
Number: 4524
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Antonangelo, R. Sales, L. Teixeira, E. Genofre, R. Onishi, M. Valim, M. Seiscento, F. Vargas (Sao Paulo, Brazil). Metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor (TGFβ) in pleural tuberculosis. Eur Respir J 2008; 32: Suppl. 52, 4524

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Paul Kelly - 07.10.2008 10:13
P Kelly
The experimet does seem to add to our knowledge of how TB effusions are produced. While there are differences in the level of response depending on whether the patients had TB or not, how confident would you be to rely on this technigue to either diagnose or exclude TB ?
You must Login to comment this presentation.


Related content which might interest you:
Effects of keratinocyte growth factor (KGF) on matrix metalloproteinases (MMPs) & tissue inhibitors of metalloproteinases (TIMPs) mRNA levels in emphysematous rats lungs
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008


Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in pleural effusions
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011


Blood levels of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix matalloproteinases (TIMPs) as biomarkers of COPD.
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018


Remodelling of extracellular matrix (ECM) differs between pulmonary adenocarcinoma (Ad) and squamous cell carcinoma (Sq): immunohistochemistry and morphometry of matrix proteins (MPs), matrix metalloproteinases (MMPs), and tissue inhibitors of MMPs (TIMPs
Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Year: 2008


Matrix metalloproteinases (MMPs) and angiogenesis in lung tissue remodeling in different variants of idiopathic interstitial pneumonia (IIP)
Source: Eur Respir J 2007; 30: Suppl. 51, 137s
Year: 2007

Matrix metalloproteinases in tuberculosis
Source: Eur Respir J 2011; 38: 456-464
Year: 2011



Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF
Source: Eur Respir J 2002; 20: 1220-1227
Year: 2002



Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions
Source: Eur Respir J 2005; 25: 104-109
Year: 2005



Remodelling of extracellular matrix (ECM) differs between tumor centre and invasion front in human non-small cell lung cancer: immunohistochemistry and morphometry of matrix proteins (MP), matrix metalloproteinases (MMPs), and tissue inhibitors of MMPs (T
Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Year: 2008

The genetic polymorphism of metalloproteinases MMP2, 7, 9 and MMP inhibitor TIMP2 in sarcoidosis
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011


Expression of matrix metalloproteinases (MMPs) in primary spontaneous pneumothorax: MMP-9 as a potential biomarker for surgical intervention
Source: International Congress 2017 – Thoracic surgery
Year: 2017

Biological role of matrix metalloproteinases: a critical balance
Source: Eur Respir J 2011; 37: 191-208
Year: 2011



The role of matrix metalloproteinase- 9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMMP-1) in sarcoidosis and idiopathic pulmonary fibrosis. Correlation with echocardiography
Source: Eur Respir J 2006; 28: Suppl. 50, 745s
Year: 2006

Metalloproteinases, tissue inhibitors of metalloproteinases and TGF-β as predictors of pleura thickening in pleural tuberculosis
Source: Annual Congress 2009 - Diagnostic advances in tuberculosis
Year: 2009


Statins inhibit matrix metalloproteinase release from human lung fibroblasts
Source: Eur Respir J 2010; 35: 637-646
Year: 2010



Matrix metalloproteinases (MMPs), tissue inhibitor of matrix metalloproteinases (TIMPs) and transforming growth factor-β (TGFβ) expression in small airways (SA) of usual idiopathic pneumonia (UIP), non-specific interstitial pneumonia (NSIP), hip
Source: Annual Congress 2007 - Role of genomics and biological tools in the work-up of interstitial lung disease
Year: 2007


Matrix metalloproteinases and their inhibitors in pulmonary hypertension},
Source: Eur Respir J 2012; 40: 766-782
Year: 2012



Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases expression in the bronchial secretions of asthmatics and COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 92s
Year: 2002

Quantitative assessment of matrix metalloproteinasis 7 (MMP-7) and tissue inhibitor of MMP-7 (TIMP1) in NSCLC tissue samples
Source: Eur Respir J 2006; 28: Suppl. 50, 813s
Year: 2006

High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation
Source: Eur Respir J 2009; 33: 134-141
Year: 2009